Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study (AFIRE Study)

NCT02642419 is registered in ClinicalTrials.gov with Japan Cardiovascular Research Foundation as lead sponsor.

NCT NCT02642419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02642419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study (AFIRE Study)
Lead sponsor
Japan Cardiovascular Research Foundation
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2015
Completion date
December 31, 2017
Enrollment
2,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation